IQVIA has made Veeva CTMS, eTMF, Study Startup and Site Connect enterprise standards across its clinical development studies, ...

Fortrea rescued a Phase III hypercholesterolemia trial enrollment by using pre-screening logs and targeted site interventions ...

ICU staffing emerges as critical factor in ARDS trial enrollment, with site selection now prioritizing round-the-clock ...

AHN Cancer Center launches RANDY'S Trial to test FDA-approved drugs for treating peritoneal fibrosis in abdominal cancer ...

Evident launches Pramana POD scanner for small pathology labs, processing 25 slides per hour with built-in quality assessment ...

Masimo smartSET gains FDA clearance for AFib and opioid depression detection, adding AI-driven pattern recognition to pulse ...

Base editing reached human trials, but the FDA's April 2026 NGS safety draft guidance reveals how far the regulatory ...

FDA grants priority review to BridgeBio's oral infigratinib for pediatric achondroplasia, offering a once-daily pill ...

XS411 Parkinson's cell therapy demonstrated five hours of daily ON-time gain in Phase I, with no serious adverse events ...

Vanda Pharmaceuticals' VQW-765 fails primary endpoint in Phase III social anxiety trial, showing no statistically significant ...

Zenas BioPharma releases Phase 3 obexelimab IgG4-related disease data with open-label extension results showing durability ...

CluePoints earns third Scrip Awards shortlisting in eight years for its risk-based quality management software serving ...